These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35081362)
1. Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex. Hsiao CC; Nguyen K; Jin Y; Vinogradova O; Wiemer AJ Cell Chem Biol; 2022 Jun; 29(6):985-995.e5. PubMed ID: 35081362 [TBL] [Abstract][Full Text] [Related]
2. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells. Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935 [TBL] [Abstract][Full Text] [Related]
3. Mutations to the BTN2A1 Linker Region Impact Its Homodimerization and Its Cytoplasmic Interaction with Phospho-Antigen-Bound BTN3A1. Nguyen K; Jin Y; Howell M; Hsiao CC; Wiemer AJ; Vinogradova O J Immunol; 2023 Jul; 211(1):23-33. PubMed ID: 37171180 [TBL] [Abstract][Full Text] [Related]
4. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells. Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084 [TBL] [Abstract][Full Text] [Related]
5. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing. Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate analogs as competitive partial agonists of butyrophilin 3A1. Singh R; Rani S; Jin Y; Hsiao CC; Wiemer AJ Eur J Med Chem; 2024 Oct; 276():116673. PubMed ID: 39029338 [TBL] [Abstract][Full Text] [Related]
7. A Photo-Crosslinkable Biotin Derivative of the Phosphoantigen (E)-4-Hydroxy-3-Methylbut-2-Enyl Diphosphate (HMBPP) Activates Vγ9Vδ2 T Cells and Binds to the HMBPP Site of BTN3A1. Mattarei A; Enzinger M; Gu S; Karunakaran MM; Kimmel B; Berner N; Adams EJ; Herrmann T; Amslinger S Chemistry; 2017 Sep; 23(49):11945-11954. PubMed ID: 28631855 [TBL] [Abstract][Full Text] [Related]
8. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells. Rigau M; Ostrouska S; Fulford TS; Johnson DN; Woods K; Ruan Z; McWilliam HEG; Hudson C; Tutuka C; Wheatley AK; Kent SJ; Villadangos JA; Pal B; Kurts C; Simmonds J; Pelzing M; Nash AD; Hammet A; Verhagen AM; Vairo G; Maraskovsky E; Panousis C; Gherardin NA; Cebon J; Godfrey DI; Behren A; Uldrich AP Science; 2020 Feb; 367(6478):. PubMed ID: 31919129 [TBL] [Abstract][Full Text] [Related]
10. The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region. Nguyen K; Li J; Puthenveetil R; Lin X; Poe MM; Hsiao CC; Vinogradova O; Wiemer AJ FASEB J; 2017 Nov; 31(11):4697-4706. PubMed ID: 28705810 [TBL] [Abstract][Full Text] [Related]
11. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation. Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997 [TBL] [Abstract][Full Text] [Related]
12. Phosphoantigen sensing combines TCR-dependent recognition of the BTN3A IgV domain and germline interaction with BTN2A1. Willcox CR; Salim M; Begley CR; Karunakaran MM; Easton EJ; von Klopotek C; Berwick KA; Herrmann T; Mohammed F; Jeeves M; Willcox BE Cell Rep; 2023 Apr; 42(4):112321. PubMed ID: 36995939 [TBL] [Abstract][Full Text] [Related]
13. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins. Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807 [TBL] [Abstract][Full Text] [Related]
14. Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More. Herrmann T; Karunakaran MM Front Immunol; 2022; 13():876493. PubMed ID: 35371078 [TBL] [Abstract][Full Text] [Related]
16. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing. Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T Nat Commun; 2023 Nov; 14(1):7617. PubMed ID: 37993425 [TBL] [Abstract][Full Text] [Related]
17. Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2 Lai AY; Patel A; Brewer F; Evans K; Johannes K; González LE; Yoo KJ; Fromm G; Wilson K; Schreiber TH; de Silva S J Immunol; 2022 Oct; 209(8):1475-1480. PubMed ID: 36096643 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters. Rhodes DA; Chen HC; Williamson JC; Hill A; Yuan J; Smith S; Rhodes H; Trowsdale J; Lehner PJ; Herrmann T; Eberl M Front Immunol; 2018; 9():662. PubMed ID: 29670629 [TBL] [Abstract][Full Text] [Related]
19. [Butyrophilin 3A1 (BTN3A1) enhances activation and proliferation of human peripheral blood Vγ9Vδ2 T cells induced by MTB-HAg]. Tang J; Sun J; Zha C; Chang J; Hu K; Fang Q; Chen Y; Chen J; Li B Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):680-686. PubMed ID: 32958123 [TBL] [Abstract][Full Text] [Related]
20. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells. Riganti C; Castella B; Massaia M Front Immunol; 2018; 9():1246. PubMed ID: 29937767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]